title: Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
abstract: In Parkinson's disease (PD), there is increasing evidence for disorders in the impulsive-compulsive spectrum, related to the disease itself, to the pharmacological management of this disease or to both. These disorders comprise dopamine deficiency syndrome (with immediate reward seeking behaviour), dopamine dependency syndrome (with addictive behaviour), dopamine dysregulation syndrome (with both addictive behaviour and stereotyped behaviour) and impulse control disorders (such as pathological gambling, compulsive shopping, binge eating and hypersexuality). These disorders are especially seen in PD patients with young age of onset, higher doses of antiparkinsonian drugs, pre-existent or current depression, pre-existing recreational drug or alcohol use, and high novelty seeking personality traits.Dopamine is not only implicated in voluntary movement control but also plays a significant role in the brain's reward system and the modulation of behaviours. Therefore, most if not all drugnaïve PD patients will suffer dysphoria, leading to mild immediate reward seeking behaviour as a consequence of the striatal dopaminergic denervation. In some of these patients, during treatment, this may even lead to the intake of increasing quantities of levodopa, above those required to adequately treat motor parkinsonism, with all characteristics of a dopamine dependence syndrome. These patients may develop plastic changes in the striatal matrix leading to hyperkinesia, caused by extracellular striatal dopaminergic fluctuations due to pulsatile dopamine replacement therapy. As soon as these changes are also seen in the striatal striosomes, in the framework of a dopamine dysregulation syndrome, stereotyped behaviours (punding) may occur (supposedly due to dorsal versus ventral striatal overactivity). Finally, impulse control disorders are suggested as being pure adverse side-effects of dopamine replacement therapy. Obsessive-compulsive behaviour (caused by ventral to dorsal overactivity) so far has not been described in PD patients.Treatment of impulse control disorders is related to the underlying pathology. In the case of an intrinsic dopamine deficiency syndrome, treatment with dopamine replacement therapy, especially levodopa, will help. In the multifactorial (intrinsic and extrinsic) dopamine dependency and dysregulation syndromes, addictive behaviour might best be helped by psychosocial strategies, and punding by continuous dopaminergic receptor stimulation (or amantadine), hypothesized to reduce the plastic changes-induced hypersensitization. The extrinsic impulse control disorders might be best treated by reducing or replacing dopamine receptor agonists.
authors.affiliation: Dept. of Neurology, VU University Medical Center, Amsterdam, The Netherlands. E.Wolters@vumc.nl
authors.forename: Eric Ch
authors.initials: ECh
authors.lastname: Wolters
authors.forename: Ysbrand D
authors.initials: YD
authors.lastname: van der Werf
authors.forename: Odile A
authors.initials: OA
authors.lastname: van den Heuvel
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000139:chemically induced / Q000503:physiopathology*; D004298:Dopamine / Q000378:metabolism; D005715:Gambling / Q000523:psychology; D006801:Humans; D007175:Impulsive Behavior / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*
chemical_list: D000978:Antiparkinson Agents; D004298:Dopamine
references.citation: Mov Disord. 2007 Jun 15;22(8):1179-81
references.pmid: 17230464
references.citation: J Neural Transm (Vienna). 2004 Oct;111(10-11):1303-15
references.pmid: 15480840
references.citation: Curr Opin Neurol. 2007 Aug;20(4):484-92
references.pmid: 17620886
references.citation: J Clin Psychiatry. 1996;57 Suppl 8:3-6
references.pmid: 8698678
references.citation: Mov Disord. 2008 Feb 15;23(3):411-5
references.pmid: 18067187
references.citation: Mov Disord. 2004 Apr;19(4):397-405
references.pmid: 15077237
references.citation: Ann Neurol. 2006 May;59(5):733-4
references.pmid: 16634013
references.citation: Mov Disord. 2000 Jul;15(4):669-77
references.pmid: 10928577
references.citation: J Neuropsychiatry Clin Neurosci. 2003 Summer;15(3):371-4
references.pmid: 12928516
references.citation: Eur J Pharmacol. 2005 Dec 5;526(1-3):199-206
references.pmid: 16256105
references.citation: Arch Gen Psychiatry. 2005 Aug;62(8):922-33
references.pmid: 16061770
references.citation: Parkinsonism Relat Disord. 2005 May;11(3):139-45
references.pmid: 15823477
references.citation: Neurology. 2006 Oct 10;67(7):1254-7
references.pmid: 16957130
references.citation: J Neural Transm Suppl. 2006;(70):309-19
references.pmid: 17017546
references.citation: Parkinsonism Relat Disord. 2005 Mar;11(2):85-8
references.pmid: 15734665
references.citation: Mov Disord. 2000 Sep;15(5):869-72
references.pmid: 11009192
references.citation: Behav Brain Res. 2005 Feb 28;157(2):253-63
references.pmid: 15639176
references.citation: Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
references.pmid: 12498954
references.citation: Synapse. 2002 Jan;43(1):1-11
references.pmid: 11746728
references.citation: Biol Psychiatry. 1994 Sep 1;36(5):350-1
references.pmid: 7993965
references.citation: Arch Neurol. 2007 Feb;64(2):212-6
references.pmid: 17296836
references.citation: J Neurol. 2000 Apr;247 Suppl 2:II103-9
references.pmid: 10991655
references.citation: Neuroscience. 2005;136(4):1049-71
references.pmid: 16226842
references.citation: Parkinsonism Relat Disord. 2005 Sep;11(6):381-6
references.pmid: 16109498
references.citation: Pract Neurol. 2007 Nov;7(6):397-9
references.pmid: 18024780
references.citation: Drug Alcohol Depend. 2004 Dec 7;76(3):305-10
references.pmid: 15561481
references.citation: Arch Neurol. 2003 Dec;60(12):1745-8
references.pmid: 14676050
references.citation: Arch Neurol. 2006 Jul;63(7):969-73
references.pmid: 16831966
references.citation: J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):423-8
references.pmid: 10727476
references.citation: Arch Neurol. 2005 Sep;62(9):1377-81
references.pmid: 16009751
references.citation: Mov Disord. 2007 Dec;22(16):2339-45
references.pmid: 17914729
references.citation: J Clin Psychopharmacol. 2007 Feb;27(1):107-8
references.pmid: 17224732
references.citation: J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):394-6
references.pmid: 11181867
references.citation: J Neurol Sci. 2008 Mar 15;266(1-2):216-28
references.pmid: 17804018
references.citation: J Neurol Neurosurg Psychiatry. 1999 Oct;67(4):492-6
references.pmid: 10486397
references.citation: J Neurosci. 2004 Aug 25;24(34):7557-65
references.pmid: 15329403
references.citation: Parkinsonism Relat Disord. 2008;14(1):28-32
references.pmid: 17702628
references.citation: J Neurosci. 2000 Mar 15;20(6):2369-82
references.pmid: 10704511
references.citation: Parkinsonism Relat Disord. 2007 Dec;13(8):516-9
references.pmid: 17544807
references.citation: Mov Disord. 2008 Jan;23(1):75-80
references.pmid: 17960796
references.citation: Neurology. 2003 Feb 25;60(4):601-5
references.pmid: 12601099
references.citation: Stroke. 2007 Apr;38(4):1390-2
references.pmid: 17332454
references.citation: Brain Dev. 2003 Dec;25 Suppl 1:S3-S14
references.pmid: 14980365
references.citation: Mov Disord. 2008 Jan;23(1):129-30
references.pmid: 17960816
references.citation: Mov Disord. 2006 Dec;21(12):2214-7
references.pmid: 17013916
references.citation: Eur J Nucl Med. 1999 Feb;26(2):171-82
references.pmid: 9933352
references.citation: J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):222-8
references.pmid: 11449029
references.citation: Lancet Neurol. 2003 Oct;2(10):595-604
references.pmid: 14505581
references.citation: World Psychiatry. 2007 Feb;6(1):14-8
references.pmid: 17342214
references.citation: Brain. 2005 Jun;128(Pt 6):1314-22
references.pmid: 15716302
references.citation: J Clin Psychiatry. 1995;56 Suppl 4:3-6; discussion 53-5
references.pmid: 7713863
references.citation: J Neurol Sci. 2008 Mar 15;266(1-2):197-203
references.pmid: 17854836
references.citation: Mov Disord. 2002 Nov;17(6):1371-4
references.pmid: 12465087
references.citation: Ann Neurol. 2006 May;59(5):852-8
references.pmid: 16557571
references.citation: Curr Opin Neurol. 2004 Aug;17(4):393-8
references.pmid: 15247533
references.citation: Neurology. 2006 Jun 13;66(11):1750-2
references.pmid: 16769956
references.citation: Prog Brain Res. 1990;85:119-46
references.pmid: 2094891
references.citation: Am J Psychiatry. 2006 Oct;163(10):1806-12
references.pmid: 17012693
references.citation: Prog Brain Res. 1990;85:95-116; discussion 116-8
references.pmid: 2094917
references.citation: Nat Clin Pract Neurol. 2007 Dec;3(12):664-72
references.pmid: 18046439